[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350755-105":59,"doc-detail-350755-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-pan-cancer-analysis-and-experimental-validation-of-mitotic-arrest-defective-2-like-1-mad2l1-in-colorectal-cancer","Comprehensive pan-cancer analysis and experimental validation of mitotic arrest defective 2-like 1 (MAD2L1) in colorectal cancer","","Comprehensive pan-cancer analysis and experimental validation assess mitotic arrest defective 2-like 1 (MAD2L1) in colorectal cancer (CRC). MAD2L1 shows diagnostic and prognostic value across cancers, with expression linked to methylation patterns, immune infiltration, and immune checkpoint genes. A lncRNA–miRNA–MAD2L1 regulatory network is constructed for CRC, enriched for DNA replication and chromosome segregation. In functional experiments, MAD2L1 promotes proliferation and suppresses apoptosis, likely through cell-cycle regulation, supporting its potential as a biomarker and therapeutic sensitivity indicator.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-pan-cancer-analysis-and-experimental-validation-of-mitotic-arrest-defective-2-like-1-mad2l1-in-colorectal-cancer/350755/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-pan-cancer-analysis-and-experimental-validation-of-mitotic-arrest-defective-2-like-1-mad2l1-in-colorectal-cancer/350755.png","ImageObject",300,407,{"name":92,"@type":93},"LangkahRina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"MAD2L1在胰腺癌以外的多种肿瘤中是否具有诊断与预后价值？","Question",{"text":112,"@type":113},"综合的pan-cancer分析表明，MAD2L1具有诊断与预后相关价值，并且其表达与甲基化、免疫浸润以及免疫检查点基因相关。","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"研究如何在CRC中建立MAD2L1相关的ceRNA网络？",{"text":117,"@type":113},"在CRC中构建了lncRNA–miRNA–MAD2L1调控网络，并通过共表达/富集分析对相关基因功能进行了关联。",{"name":119,"@type":110,"acceptedAnswer":120},"MAD2L1的功能实验结果支持其发挥怎样的生物学作用？",{"text":121,"@type":113},"功能实验显示MAD2L1促进细胞增殖并抑制凋亡，且与细胞周期调控相关；富集分析也将其联系到DNA复制与染色体分离过程。","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350755,1790283334,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962090893776,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Comprehensive pan-cancer analysis and experimental validation of mitotic arrest defective 2-like 1 (MAD2L1) in colorectal cancer  \nQingqing Wu1 ID , Zhuangzhuang Tian1, Liyu Cao2* ID  \n1Department of Pathology, the Fuyang Affiliated Hospital of Anhui Medical University, Fuyang, Anhui, 236000, China 2Department of Pathology, Anhui Medical University, Hefei, Anhui, 230032, China  \nArticle Info  \nArticle Type:  \nOriginal Article  \nArticle History:  \nReceived: 13 Sep. 2025  \nRevised: 17 Nov. 2025  \nAccepted: 29 Nov. 2025  \nePublished: 30 Jun. 2026  \nKeywords:  \nColorectal cancer Integrative analysis MAD2L1  \nPan-cancer analysis  \nimmune infiltration, and copper apoptosis-related genes across multiple cancers. A lncRNA– miRNA–MAD2L1 regulatory network was constructed for CRC. Drug sensitivity related to MAD2L1 was assessed via GSCALite. Functional assays included GO/KEGG enrichment, RTPCR, Western blot, CCK-8, cell cycle, and apoptosis analysis.  \nResults: A comprehensive pan-cancer analysis revealed that MAD2L1 has diagnostic and prognostic value. Its expression correlated with methylation, immune cell infiltration, and immune checkpoint genes. In CRC, a lncRNA–miRNA–MAD2L1 network appears to regulate tumor progression. Enrichment analysis linked MAD2L1 to DNA replication and chromosome segregation. Functional experiments showed that MAD2L1 promotes proliferation and inhibits apoptosis, likely via cell cycle regulation.  \nConclusion: MAD2L1 is a potential biomarker for diagnosis, prognosis, immune response, and drug sensitivity in pan-cancer, including CRC. It facilitates tumor progression through a lncRNAmiRNA–miRNA network and regulates proliferation and apoptosis via DNA replication and cell cycle pathways.  \nIntroduction  \nColorectal cancer (CRC) ranks asthe third most frequently diagnosed cancer globally, yet it stands as the second leading cause of death among cancer patients. Advancesin understanding the molecular pathogenesis of CRC have broadened the spectrum of available treatments, which include endoscopic and surgical resection, radiotherapy, immunotherapy, targeted therapies, palliative chemotherapy, extensive surgical interventions, and local ablative approaches for metastatic disease. 1,2 Despite improvements in therapeutic avenues, the rising incidence and unfavorable outcomes observed in younger age groups present considerable economic and public  \nhealth burdens.3-5 This pressing situation highlights the need to identify innovative prognostic biomarkers and molecular targets to enhance treatment personalization and outcome prediction for individuals with colorectal cancer.  \nMAD2L1, a crucial component of the MAD family, is located on human chromosome 4 and plays a pivotal role in the mitotic checkpoint complex.6 Disruptionsin MAD2L1 function can adversely affect the mitotic checkpoint's integrity. Research has indicated that MAD2L1 mutations foster tumor growth through chromosomal instability and aneuploidy, noted in various human cancers, including lung adenocarcinoma  \n*Corresponding author: Liyu Cao, [Email: wfy130409@fy.ahmu.edu.cn](Email: wfy130409@fy.ahmu.edu.cn)  \n © 2026 The Author(s) . This work is published by BioImpacts as an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License ([http://creativecommons.org/licenses/by-nc/4.0/](http://creativecommons.org/licenses/by-nc/4.0/)). Non-commercial uses of the work are permitted, provided the original work is properly cited.  \n(LUAD), CRC, cervical cancer, liver cancer, breast cancer (BRCA), and gastric cancer.7-12 These findings underscore MAD2L1's significant role in oncogenesis.  \nThere is a well-documented correlation between MAD2L1 overexpression and its prognostic significance in tumors.13 It has been observed that MAD2L1 enhances proliferation and inhibits apoptosis in LUAD cells, and is linked to malignant progression and poor disease-free survival in BRCA patients.14 Nonetheless, the association b","cbCaimErd7QTfs8Y","https://ap.wps.com/l/cbCaimErd7QTfs8Y","pdf",11285307,15,"English","# Article Info\n# Introduction\n# Materials and Methods","[{\"question\":\"MAD2L1在胰腺癌以外的多种肿瘤中是否具有诊断与预后价值？\",\"answer\":\"综合的pan-cancer分析表明，MAD2L1具有诊断与预后相关价值，并且其表达与甲基化、免疫浸润以及免疫检查点基因相关。\"},{\"question\":\"研究如何在CRC中建立MAD2L1相关的ceRNA网络？\",\"answer\":\"在CRC中构建了lncRNA–miRNA–MAD2L1调控网络，并通过共表达/富集分析对相关基因功能进行了关联。\"},{\"question\":\"MAD2L1的功能实验结果支持其发挥怎样的生物学作用？\",\"answer\":\"功能实验显示MAD2L1促进细胞增殖并抑制凋亡，且与细胞周期调控相关；富集分析也将其联系到DNA复制与染色体分离过程。\"}]","Comprehensive pan-cancer analysis and experimental validation of mitotic arrest defective 2-like 1 (MAD2L1) in colorectal cancer | PDF",1790090923,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bb937ac4a2d8272cc43e5e1c7ed51168.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e140ac571caf4706d506b37179d4f31.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/450d27bdcb76f48203fc353906d80c24.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d475c134871d37c637709c0e44618d65.webp",980,1385]